Fig. 8From: Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancerPCA analysis of different model groups in high and low risk patients. A all gene group. B cuproptosis gene group. C cuproptosis lncRNA group. D risk lncRNA groupBack to article page